2023 (47 POSTS)
Dhyani VS, Krishnan JB, Mathias EG, Hossain MM, Price C , Gudi N, et al. 2023. Barriers and facilitators for the adoption of telemedicine services in low-income and middle-income countries: A rapid overview of reviews. BMJ Innovat 9(4):215-225; doi: 10.1136/bmjinnov-2022-001062 .
View Abstract
Topics: Systematic Review
Henderson RG , Franke KS , Payne LE, Franzen A . 2023. Cannabidiol safety data: A systematic mapping study. Cannabis Cannabinoid Res 8(1):34–40; doi: 10.1089/can.2022.0100 . PMID: 36251454.
View Abstract
Topics: Cannabinoid/Industrial Hemp , cannabis , Systematic Review
Li H, Krall JR, Frankenfeld C , Slavin M. 2023. Nutritional intake of riboflavin (vitamin B2) and probable migraine: A cross-sectional analysis of the National Health and Nutrition Examination Survey (NHANES) 2001-2004. Nutr Neurosci 26(11):1068-1077; doi: https://doi.org/10.1080/1028415X.2022.2126760 . PMID: 36175363.
View Abstract
Topics: Epidemiology , Food science
Henderson RG , Lefever TW, Heintz MM , Trexler KR, Borghoff SJ , Bonn-Miller MO. 2023. Oral toxicity evaluation of cannabidiol. Food Chem Toxicol 176(June):113786; doi: 10.1016/j.fct.2023.113778 . PMID: 37105391.
View Abstract
Topics: Cannabinoid/Industrial Hemp , Toxicology
Henderson RG , Welsh BT, Rogers JM , Borghoff SJ , Trexler KR, Bonn-Miller MO, Lefever TW. 2023. Reproductive and developmental toxicity evaluation of cannabidiol. Food Chem Toxicol 176(June):113786; doi: 10.1016/j.fct.2023.113786 . PMID: 37105390.
View Abstract
Topics: Cannabinoid/Industrial Hemp , Toxicology
Henderson RG , Welsh BT, Trexler KR, Bonn-Miller MO, Lefever TW. 2023. Genotoxicity evaluation of cannabidiol. Regul Toxicol Pharmacol 142(August):105425; doi: 10.1016/j.yrtph.2023.105425 . PMID: 37271419.
View Abstract
Topics: Cannabinoid/Industrial Hemp , Toxicology
Rogers JM, Heintz MM, Thompson CM, Haws LC . 2023. A putative adverse outcome network for neonatal mortality and lower birth weight in rodents: Applicability to per- and polyfluoroalkyl substances and relevance to human health. Birth Defects Res 115(11)1011-1062; doi: 10.1002/bdr2.2185 . PMID: 37219003.
View Abstract
Topics: Exposure Assessment , PFAS , Toxicology
Du H, Pan B, Alund AW, Yan J, Chen Y, Robison TW , Chen T. 2023. Evaluation of mutagenic susceptibility of different stages in germ cell development of Caenorhabditis elegans using whole genome sequencing. Arch Toxicol 97(8):2261-2272; doi: 10.1007/s00204-023-03526-z .
View Abstract
Buerger AN , Massarsky A, Russell A, Zoghby N, Hirn C, Mucs D, et al. 2023. Evaluation of chemical grouping workflows for flavor inhalation risk assessment: Selected furan moiety-containing chemicals as a case study. Comp Tox 26(May):100269; doi: 10.1016/j.comtox.2023.100269 .
View Abstract
Topics: risk assessment , Toxicology
Meek ME, Wikoff D . 2023. The need for good practice in the application of mechanistic constructs in hazard and risk assessment. Toxicol Sci 194(1):13-22; doi: 10.1093/toxsci/kfad039 . PMID: 3707944.
View Abstract
Topics: risk assessment , Toxicology
Kaurani P, Hindocha AD, Jayasinghe RM, Pai UY, Batra K, Price C . 2023. Effect of addition of titanium dioxide nanoparticles on the antimicrobial properties, surface roughness and surface hardness of polymethyl methacrylate: A systematic review. F1000Res 12:577; doi: 10.12688/f1000research.130028.1 .
View Abstract
Topics: nanomaterials , nanotechology , Systematic Review , titanium dioxide
Wheeler MW . 2023. An investigation of non-informative priors for Bayesian dose-response modeling. Regul Toxicol Pharmacol 141(June):105389; doi: 10.1016/j.yrtph.2023.105389 . PMCID: PMC10436774.
View Abstract
Topics: dose-response , modeling
Dalvi T, Nørgaard M, Fryzek JP, Movva N , Pedersen L, Hansen HP, et al. 2023. Biomarker expression and survival in patients with non-small cell lung cancer receiving adjuvant chemotherapy in Denmark. PLoS ONE 18(4):e0284037; doi: 10.1371/journal.pone.0284037 . PMID: 37040387.
View Abstract
Topics: Cancer , Epidemiology
Thompson CM , Heintz MM , Wolf JC, Cheru R, Haws LC , Cullen JM. 2023. Assessment of mouse liver histopathology following exposure to HFPO-DA with emphasis on understanding mechanisms of hepatocellular death. Toxicol Pathol 51(1–2):4–14; doi: 10.1177/01926233231159078 . PMID: 36987989.
View Abstract
Topics: Exposure Assessment , Toxicology
Heintz MM , Haws LC , Klaunig JE, Cullen JM, Thompson CM . 2023. Assessment of the mode of action underlying development of liver lesions in mice following oral exposure to HFPO-DA and relevance to humans. Toxicol Sci 192(1):15–29; doi: 10.1093/toxic/kfad004 . PMID: 36629480.
View Abstract
Topics: Cancer , Toxicology
Thompson CM , Proctor DM , Harris MA. 2023. Letter to “Chepelev et al. Establishing a quantitative framework for regulatory interpretation of genetic toxicity dose–response data: Margin of exposure case study of 48 compounds with both in vivo mutagenicity and carcinogenicity dose–response data.” Environ Mol Mutagen 64(4):259–260; doi: 10.1002/em.22537 . PMID: 36916184.
Topics: Hexavalent Chromium , Toxicology
Sterner TR, Covington TR , Mattie DR. 2023. Complex mixtures: Array PBPK modeling of jet fuel components. Toxics 11(2):187; doi: 10.3390/toxics11020187 . PMID: 36851061.
View Abstract
Topics: PBPK , Toxicology
Wheeler MW , Lim S, House JS, Shockley KR, Bailer AJ, Fostel J, Yang L, Talley D, Raghuraman A, Gift JS. 2023. ToxicR: A computational platform in R for computational toxicology and dose–response analyses. Comp Toxicol 25(Feb):100259; doi: 10.1016/j.comtox.2022.100259 . PMCID: PMC9997717.
View Abstract
Topics: benchmark dose estimation (BMD)
East A , Dawson DE, Brady S, Vallero DA, Tornero-Velez R. 2023. A scoping assessment of implemented toxicokinetic models of per- and polyfluoro-alkyl substances, with a focus on one-compartment models. Toxics 11(2):163; doi: 10.3390/toxics11020163 . PMID: 36851038.
View Abstract
Topics: modeling , PFAS , Toxicology
Grover A, Sankaranarayanan S, Mathur V, Suri P, Qiu H, Andrews-Zwilling Y, Mease K , Taylor LK, Cahir-McFarland E, Keswani S, Yednock T. 2023. Pharmacokinetic and target engagement measures of ANX007, an anti-C1q antibody fragment, following intravitreal administration in nonhuman primates. Invest Opthalmol Visual Sci 64(2)3; 10.1167/iovs.64.2.3 . PMID: 36729444.
View Abstract